Amicus Therapeutics, Inc., is a biopharmaceutical company that develops drugs for the treat- ment of various diseases, including Parkinson's disease. Amicus Therapeutics reported the following financial data (in thousands) for three recent years: For Years Ended December 31 Year 2 Year 3 Year 1 Cash and cash equivalents Net cash flows from operations $ 69,485 $ 24,074 $ 43,640 (100,139) (45,794) (51,669) a. Determine the monthly cash expenses for Year 3, Year 2, and Year 1. Round to one decimal place. b. Determine the ratio of cash to monthly cash expenses for Year 3, Year 2, and Year 1 as of December 31. Round to one decimal place. Based on (a) and (b), comment on Amicus Therapeutics' ratio of cash to C. monthly operating expenses for Year 3, Year 2, and Year 1.

FINANCIAL ACCOUNTING
10th Edition
ISBN:9781259964947
Author:Libby
Publisher:Libby
Chapter1: Financial Statements And Business Decisions
Section: Chapter Questions
Problem 1Q
icon
Related questions
Question
Amicus Therapeutics, Inc., is a biopharmaceutical company that develops drugs for the treat-
ment of various diseases, including Parkinson's disease. Amicus Therapeutics reported the
following financial data (in thousands) for three recent years:
For Years Ended December 31
Year 2
Year 3
Year 1
Cash and cash equivalents
Net cash flows from operations
$ 69,485
$ 24,074
$ 43,640
(100,139)
(45,794)
(51,669)
a. Determine the monthly cash expenses for Year 3, Year 2, and Year 1. Round to one
decimal place.
b. Determine the ratio of cash to monthly cash expenses for Year 3, Year 2, and Year 1
as of December 31. Round to one decimal place.
Based on (a) and (b), comment on Amicus Therapeutics' ratio of cash to
C.
monthly operating expenses for Year 3, Year 2, and Year 1.
Transcribed Image Text:Amicus Therapeutics, Inc., is a biopharmaceutical company that develops drugs for the treat- ment of various diseases, including Parkinson's disease. Amicus Therapeutics reported the following financial data (in thousands) for three recent years: For Years Ended December 31 Year 2 Year 3 Year 1 Cash and cash equivalents Net cash flows from operations $ 69,485 $ 24,074 $ 43,640 (100,139) (45,794) (51,669) a. Determine the monthly cash expenses for Year 3, Year 2, and Year 1. Round to one decimal place. b. Determine the ratio of cash to monthly cash expenses for Year 3, Year 2, and Year 1 as of December 31. Round to one decimal place. Based on (a) and (b), comment on Amicus Therapeutics' ratio of cash to C. monthly operating expenses for Year 3, Year 2, and Year 1.
Expert Solution
trending now

Trending now

This is a popular solution!

steps

Step by step

Solved in 3 steps with 3 images

Blurred answer
Similar questions
Recommended textbooks for you
FINANCIAL ACCOUNTING
FINANCIAL ACCOUNTING
Accounting
ISBN:
9781259964947
Author:
Libby
Publisher:
MCG
Accounting
Accounting
Accounting
ISBN:
9781337272094
Author:
WARREN, Carl S., Reeve, James M., Duchac, Jonathan E.
Publisher:
Cengage Learning,
Accounting Information Systems
Accounting Information Systems
Accounting
ISBN:
9781337619202
Author:
Hall, James A.
Publisher:
Cengage Learning,
Horngren's Cost Accounting: A Managerial Emphasis…
Horngren's Cost Accounting: A Managerial Emphasis…
Accounting
ISBN:
9780134475585
Author:
Srikant M. Datar, Madhav V. Rajan
Publisher:
PEARSON
Intermediate Accounting
Intermediate Accounting
Accounting
ISBN:
9781259722660
Author:
J. David Spiceland, Mark W. Nelson, Wayne M Thomas
Publisher:
McGraw-Hill Education
Financial and Managerial Accounting
Financial and Managerial Accounting
Accounting
ISBN:
9781259726705
Author:
John J Wild, Ken W. Shaw, Barbara Chiappetta Fundamental Accounting Principles
Publisher:
McGraw-Hill Education